[Clinical trial of the new coronary dilator hexobendine].
D000328:Adult; D000368:Aged; D001161:Arteriosclerosis / Q000188:drug therapy; D001775:Blood Circulation / Q000187:drug effects; D001794:Blood Pressure / Q000187:drug effects; D002302:Cardiac Output / Q000187:drug effects; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000188:drug therapy*; D003331:Coronary Vessels / Q000187:drug effects; D003864:Depression, Chemical; D004361:Drug Tolerance; D004562:Electrocardiography; D005029:Ethylenediamines / Q000494:pharmacology / Q000627:therapeutic use*; D005080:Exercise Test; D005260:Female; D006333:Heart Failure / Q000188:drug therapy; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy; D009206:Myocardium / Q000378:metabolism; D010101:Oxygen Consumption / Q000187:drug effects; D010919:Placebos; D014655:Vascular Resistance / Q000187:drug effects; D014665:Vasodilator Agents / Q000627:therapeutic use*
D005029:Ethylenediamines; D010919:Placebos; D014665:Vasodilator Agents
Klinische Prüfung des neuen Coronardilatators Hexobendin.